Anna Bustin, PharmD, BCPPS

female silhouette icon
Anna Bustin, PharmD, BCPPS, is a residency preceptor with the Pharmacy Residency Program and a clinical pharmacy specialist in Neonatal / Infant Intensive Care at Children's Hospital of Philadelphia.

Areas of Expertise: Neonatology, Parenteral nutrition, Pulmonary hypertension, Critical Care
Locations: Main Hospital
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

Education and Training

Residency

Pharmacy Practice (PGY 1) - Children’s Hospital of Philadelphia, Philadelphia, PA

Pediatric Specialty (PGY 2) - Children’s Hospital of Philadelphia, Philadelphia, PA

Board Certification

Basic Life Support (BLS)
Board Certified Pediatric Pharmacotherapy Specialist (BCPPS)
Pediatric Advanced Life Support (PALS)
Pharmacy-based Immunization Certification

Undergraduate Degree

BS in Nutrition, University of Tennessee, Knoxville, TN

Graduate Degree

PharmD - Lipscomb University College of Pharmacy, Nashville, TN

Titles and Academic Titles

Clinical Pharmacy Specialist, Neonatal / Infant Intensive Care

Residency Preceptor, Pharmacy Residency Program

Departments and Services

Research Interests

Diazoxide induced pulmonary hypertension
IV compatibility
Neonatal status epilepticus
Hypoxic ischemic encephalopathy

Publications

Posters and Presentations

2021

Salmon M, Abend NA, Bustin A, Fitzgerald MP, Flibotte J, Fung FW, Parikh D, Massey SL. Seizure Management in Neonatal Hypoxic Ischemic Encephalopathy.  Child Neurology Society 2021 Annual Meeting. Poster Presentation.  Boston, MA.  October 2021.

Serio J, Gattoline S, Collier H, Bustin A. Evaluation of sirolimus dosing in neonates and infants with lymphatic disorders.  J Pediatr Pharmacol Ther. [pending publication]

McElroy NA, Bustin A, Gattoline S.  Evaluation of the Safety of Ketorolac in Postsurgical Infants Less than Six Months of Age.  J Pediatr Pharmacol Ther. [pending publication]

Sanseau E, et al.  Pediatric Emergency Medicine Simulation Curriculum: Vitamin K Deficiency in the Newborn. MedEdPORTAL. 2021;17:11078

2020

Bustin A, Ramsey EZ, Hanna BD, Kaushal G. Compatibility of treprostinil sodium and dopamine hydrochloride during Y-site administration. Am J Health-Syst Pharm. 2020;77:649-657

2018

Monk HM, Rosano JV, Bustin A.  Characterization of the use, safety, and efficacy of hydromorphone in the neonatal and infant population.  2018 ASHP Midyear Meeting Poster Presentation.  Anaheim, California.  December 2018.

2017

Bustin A, Kaushal G, Ramsey EZ, Hanna BD.  Compatibility of Treprostinil and Dopamine during Y-site Administration.  Pulmonary Hypertension Association Meeting Poster Presentation.  Bethesda, Maryland.  October 2017.

Leadership and Memberships

Memberships in Professional Organizations

Pediatric Pharmacy Association (PPA)

American Society of Health-System Pharmacists (ASHP)